Speaking to BioSpace at the J.P. Morgan Healthcare Conference, Novartis’ chief dealmaker Ronny Gal explains why the Swiss pharma hasn’t acquired a GLP-1, and why it probably won’t.
Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos Read More »
There hasn’t been a headline-stealing deal at J.P. Morgan yet. Nevertheless, the mood is positive amid green shoots and a flurry of dealmaking to end 2025.
JPM26: Attendees Wonder, Where’s Our Big M&A Deal? Read More »
The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.
Medtronic gets FDA clearance for smart insulin pen app Read More »
Entender cuánto gasta una secadora de ropa es fundamental para gestionar tu presupuesto energético mensual. Este electrodoméstico se ha vuelto indispensable en muchos hogares, especialmente durante los meses de invierno o en espacios sin áreas de tendido. Si est& …
Guía completa sobre cuánto gasta una secadora de ropa en tu hogar Read More »
While Osberg joins Inspire without prior medtech experience, CEO Tim Herbert says the new CFO can help take the company “to the next level.”
Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter blanket’ approach to drug pricing for small companies.
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech Read More »
En un contexto donde cada vez más personas buscan alternativas de salud integrales y basadas en la evidencia, ISEIH emerge como la institución de referencia en formación especializada. El interés por la medicina natural ha experimentado un crecimiento sostenido durante la …
Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total funding, according to Rock Health.
Digital health funding increases in 2025, spurred by AI: report Read More »
Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the company is open to deals in the range of “multi tens of billions of dollars.”
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity Read More »
The FDA previously rejected Zycubo for Menkes disease in October last year, citing issues with the drug’s manufacturing facility.
Sentynl, Fortress Bounce Back With FDA Approval for Rare Pediatric Disease Read More »
